Page 288 Acute Pain Management
P. 288




(Williams
et
al,
2004
Level
III‐3).
After
complex
outpatient
knee
surgery,
femoral‐sciatic
nerve

block
provided
better
pain
relief
than
femoral
nerve
block
alone,
and
both
techniques
reduced

unplanned
hospital
admissions
to
a
similar
extent
(Williams
et
al,
2003
Level
IV).

Interscalene
plexus
block
provided
safe
and
effective
analgesia
after
ambulatory
shoulder

surgery
(Bishop
et
al,
2006
Level
IV;
Faryniarz
et
al,
2006
Level
IV).
For
hand
and
wrist
surgery,

infraclavicular
nerve
blocks
with
propofol
sedation,
compared
with
general
anaesthesia

followed
by
local
anaesthetic
wound
infiltration,
resulted
in
less
postoperative
pain,
less

nausea,
earlier
ambulation
and
earlier
hospital
discharge.
(Hadzic
et
al,
2004
Level
II).

Continuous
peripheral
nerve
blockade

Patients
may
suffer
intense
pain
following
resolution
of
a
peripheral
nerve
block
although

it
maximises
pain
relief
in
the
first
12
to
24
hours
(Chung
et
al,
1997
Level
IV).
CPNB
using

perineural
catheters
and
continuous
infusions
of
local
anaesthetic
led
to
sustained

postoperative
analgesia
(Ilfeld,
Morey,
Wang
et
al,
2002
Level
II;
Ilfeld,
Morey
&
Enneking,
2002

Level
II;
Zaric
et
al,
2004
Level
II),
was
opioid‐sparing
(Ilfeld,
Morey,
Wang
et
al,
2002
Level
II;
Ilfeld,

Morey
&
Enneking,
2002
Level
II;
Ilfeld
et
al,
2003
Level
II)
and
resulted
in
less
sleep
disturbance

(Ilfeld,
Morey,
Wang
et
al,
2002
Level
II;
Ilfeld,
Morey
&
Enneking,
2002
Level
II)
and
improved

rehabilitation
(Capdevila
et
al,
1999
Level
II).
Patients
achieved
discharge
criteria
significantly

earlier
in
a
number
of
ambulatory
settings:
after
total
shoulder
arthroplasty
with
use
of

continuous
interscalene
blocks
(21
vs
51
hours)
(Ilfeld
et
al,
2006
Level
II);
after
hip
arthroplasty

with
use
of
continuous
lumbar
plexus
block
(29
vs
52
hours)
(Ilfeld,
Ball
et
al,
2008
Level
II);
and

after
total
knee
arthroplasty
with
the
use
of
continuous
femoral
nerve
blocks
(25
vs
71
hours)

(Ilfeld,
Le
et
al,
2008
Level
II).
These
benefits
have
the
potential
to
reduce
hospital
costs
(Ilfeld
et

al,
2007
Level
III‐3).

Compared
with
a
single‐injection
interscalene
block,
a
2‐day
interscalene
infusion
at
home

after
shoulder
surgery
was
opioid‐sparing
and
improved
pain
relief,
sleep
and
patient

satisfaction
(Mariano
et
al,
2009
Level
II).

Patient‐controlled
delivery
of
the
infusion
improved
analgesia
and
function
more
than
a

continuous
infusion
and
even
more
so
compared
with
IV
morphine
PCA
(Capdevila
et
al,
2006

Level
II).


CHAPTER
9
 (Swenson
et
al,
2006
Level
IV;
Fredrickson
et
al,
2008
Level
IV)
and
paediatric
patients
(Ganesh
et
al,

The
safety
and
efficacy
of
CPNBs
in
an
ambulatory
setting
has
been
confirmed
in
adult


2007
Level
IV;
Ludot
et
al,
2008
Level
IV).

Inadvertent
intravascular
catheter
placement
should
be
excluded
prior
to
patient
discharge

using
a
test
dose
of
local
anaesthetic
and
adrenaline
(epinephrine)
(Rawal
et
al,
2002).
Patients

and
their
carers
should
be
given
extensive
oral
and
written
instructions
about
management,

side
effects
and
care
of
the
local
anaesthetic
catheter,
and
have
24‐hour
a
day
telephone

access
to
an
anaesthesiologist
during
the
postoperative
period
while
CNPB
is
in
use
(Swenson
et

al,
2006),
as
30%
of
patients
make
unscheduled
phone
calls
regarding
catheter
infusions

despite
been
given
adequate
written
and
verbal
instructions
(Ilfeld,
Morey
&
Enneking,
2002

Level
II).
A
review
of
620
outpatients
with
CPNB
(including
popliteal
fossa,
fascia
iliaca
and

interscalene)
showed
that
4.2%
required
assistance
by
the
anaesthesiologist
after
discharge

from
hospital
for
problems
relating
to
issues
such
as
patient
education,
inadequate
analgesia

and
equipment
malfunction;
only
one
patient
was
unable
to
remove
their
catheter
(Swenson
et

al,
2006
Level
IV),
although
patients
may
have
significant
anxiety
about
catheter
removal
at

home
(Ilfeld
et
al,
2004
Level
IV).

Detailed
reviews
of
the
use
of
CPNBs
for
ambulatory
surgery
have
been
published
(Cheng
et
al,

2008;
Ilfeld
&
Enneking,
2005).


240
 Acute
Pain
Management:
Scientific
Evidence

   283   284   285   286   287   288   289   290   291   292   293